© 2020 MJH Life Sciences and HCPLive. All rights reserved.
Huntington Disease
Rare Genomics Institute Launches Free Rare Disease Device Program
February 29, 2020
Article
The RareWear program is designed to bridge medical device companies to rare disease patient applicants, seeking better disease and treatment monitoring.
Medicare Part D Bills Could Harm Rare Disease Drug Development
February 29, 2020
Article
New research suggests proposals aimed at reducing out of pocket costs may harm minimally-funded drug developers.
FDA Clears Gene Therapy for Huntington Disease Assessment
January 22, 2019
Article
An Investigational New Drug application was approved to clinically assess AMT-130 as the first potential drug marketed for the neurodegenerative disease.
D-PUFA Drug Candidate Shows Cognitive Improvement in Huntington Disease Patients
July 10, 2018
Article
An isotopic-reinforced polyunsaturated fatty acids shows a reduction in cognitive deficits in a preclinical in vivo model of Huntington disease.
Coenzyme Q10 Well-tolerated in Patients with Huntington Disease Participating in a Multi-center Phase II Trial
October 15, 2013
Article
Results from the first multi-center interventional trial in premanifest HD research show that the antioxidant Coenzyme Q10 is associated with only mild or moderate side effects, even at higher doses.